213 related articles for article (PubMed ID: 19073965)
21. Rational design of inhibitors that bind to inactive kinase conformations.
Liu Y; Gray NS
Nat Chem Biol; 2006 Jul; 2(7):358-64. PubMed ID: 16783341
[TBL] [Abstract][Full Text] [Related]
22. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
Lebakken CS; Hee Chol Kang ; Vogel KW
J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
[TBL] [Abstract][Full Text] [Related]
23. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
24. Predicting polypharmacology by binding site similarity: from kinases to the protein universe.
Milletti F; Vulpetti A
J Chem Inf Model; 2010 Aug; 50(8):1418-31. PubMed ID: 20666497
[TBL] [Abstract][Full Text] [Related]
25. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
[TBL] [Abstract][Full Text] [Related]
26. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform.
Von Leoprechting A; Kumpf R; Menzel S; Reulle D; Griebel R; Valler MJ; Büttner FH
J Biomol Screen; 2004 Dec; 9(8):719-25. PubMed ID: 15634799
[TBL] [Abstract][Full Text] [Related]
27. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
Horton RA; Vogel KW
J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
[TBL] [Abstract][Full Text] [Related]
28. A quantitative analysis of kinase inhibitor selectivity.
Karaman MW; Herrgard S; Treiber DK; Gallant P; Atteridge CE; Campbell BT; Chan KW; Ciceri P; Davis MI; Edeen PT; Faraoni R; Floyd M; Hunt JP; Lockhart DJ; Milanov ZV; Morrison MJ; Pallares G; Patel HK; Pritchard S; Wodicka LM; Zarrinkar PP
Nat Biotechnol; 2008 Jan; 26(1):127-32. PubMed ID: 18183025
[TBL] [Abstract][Full Text] [Related]
29. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
[TBL] [Abstract][Full Text] [Related]
30. Designing screens: how to make your hits a hit.
Walters WP; Namchuk M
Nat Rev Drug Discov; 2003 Apr; 2(4):259-66. PubMed ID: 12669025
[TBL] [Abstract][Full Text] [Related]
31. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
32. Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.
Gong LL; Fang LH; Peng JH; Liu AL; Du GH
J Biotechnol; 2010 Feb; 145(3):295-303. PubMed ID: 19963024
[TBL] [Abstract][Full Text] [Related]
33. High-throughput kinase profiling as a platform for drug discovery.
Goldstein DM; Gray NS; Zarrinkar PP
Nat Rev Drug Discov; 2008 May; 7(5):391-7. PubMed ID: 18404149
[TBL] [Abstract][Full Text] [Related]
34. Compound profiling using a panel of steroid hormone receptor cell-based assays.
Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K
J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690
[TBL] [Abstract][Full Text] [Related]
35. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
[TBL] [Abstract][Full Text] [Related]
36. Selectivity of kinase inhibitor fragments.
Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
[TBL] [Abstract][Full Text] [Related]
37. Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.
Uitdehaag JC; Sünnen CM; van Doornmalen AM; de Rouw N; Oubrie A; Azevedo R; Ziebell M; Nickbarg E; Karstens WJ; Ruygrok S
J Biomol Screen; 2011 Oct; 16(9):1007-17. PubMed ID: 21873591
[TBL] [Abstract][Full Text] [Related]
38. Target-family-oriented focused libraries for kinases--conceptual design aspects and commercial availability.
Prien O
Chembiochem; 2005 Mar; 6(3):500-5. PubMed ID: 15742385
[No Abstract] [Full Text] [Related]
39. Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay.
Mett H; Hölscher K; Degen H; Esdar C; De Neumann BF; Flicke B; Freudenreich T; Holzer G; Schinzel S; Stamminger T; Stein-Gerlach M; Marschall M; Herget T
J Biomol Screen; 2005 Feb; 10(1):36-45. PubMed ID: 15695342
[TBL] [Abstract][Full Text] [Related]
40. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
Bamborough P; Drewry D; Harper G; Smith GK; Schneider K
J Med Chem; 2008 Dec; 51(24):7898-914. PubMed ID: 19035792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
